Delivery Order SPE2DB24D2205-SPE2DB25FEEXH
- Not listed
- The Defense Logistics Agency awarded a $41,453.26 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Dupixent 300 mg/2 ml pens. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $82,931.17 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on September 23, 2025, with completion scheduled for September 24, 2025. This competitively awarded, firm fixed-price delivery order represents a single-unit pharmaceutical supply transaction under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $34,160.35 delivery order on July 23, 2025, for the supply of Dupixent 300 mg/2 mL pens (2 mL vials). This non-competitive, firm fixed-price delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The contract specifies performance at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $28,587.51 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pens on July 11, 2025, with an ultimate completion date of July 14, 2025. This non-set-aside contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is the vendor's corporate office in...
- The Defense Logistics Agency awarded a $10,809.15 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pens on July 30, 2025, with completion scheduled for July 31, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The contract carries no set-aside designation and will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Dupixent 300 mg/2 mL pens with a ceiling value of $5,128.38. This firm fixed-price, non-set-aside contract is classified as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999 and extends through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $6,356.88 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Dupixent 200 mg/1.14 ml pen injectors. This firm fixed-price delivery order, which is expected to be completed by July 24, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a $3,058.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Dupixent 300 mg/2 mL pens. This non-set-aside competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $12,949.95 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors (2 mL units). This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and represents a non-set-aside award. The products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $15,942.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Dupixent 300 mg/2 mL pens. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The delivery location is AmerisourceBergen's corporate office in Conshohocken,...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEEXHDelivery Order
The Defense Logistics Agency awarded a $27,100.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Dupixent 300 mg/2 mL pens. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor serving federal military and veteran healthcare systems, was competitively selected to fulfill this medical supply requirement. As a critical vendor within DLA's Medical Supply Chain, the company maintains extensive capabilities in delivering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Dupixent, a biologics medication used in immunological treatments, exemplifies the routine pharmaceutical procurement operations conducted through AmerisourceBergen's comprehensive prime vendor agreement with the Defense Logistics Agency to support military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.1k | 7/15/25 |